4.2 Review

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

期刊

EXPERT OPINION ON EMERGING DRUGS
卷 15, 期 3, 页码 481-494

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1517/14728214.2010.487860

关键词

aripiprazole; autism; autistic disorder; methylphenidate; PDDs; risperidone; treatment

资金

  1. Roche
  2. Bristol-Myers Squibb
  3. Seaside Therapeutics
  4. Division of Disability and Rehabilitative Services, Indiana Family and Social Services Administration
  5. National Institute of Health [K12 UL1 RR025761]
  6. American Psychiatric Institute for Research and Education (APIRE)/Janssen
  7. NIMH [R01 MH072964]
  8. Janssen
  9. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER
  10. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072964] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Importance of the field: Autism spectrum disorders, or pervasive developmental disorders (PDDs), are neurodevelopmental disorders defined by qualitative impairment in social interaction, impaired communication and stereotyped patterns of behavior. The most common forms of POD are autistic disorder (autism), Asperger's disorder and PDD not otherwise specified. Recent surveillance studies reveal an increase in the prevalence of autism and related PDDs. The use of pharmacologic agents in the treatment of these disorders can reduce the impact of interfering symptoms, providing relief for affected individuals and their families. Areas covered in this review: This review examines results from neurobiologic research in an attempt to both elucidate the pathophysiology of autism and guide the development of pharmacologic agents for the treatment of associated symptoms. The safety and efficacy data of drugs currently in clinical use for the treatment of these symptoms, as well as pharmaceuticals currently under development, are discussed. What the reader will gain: This comprehensive review will deepen the reader's current understanding of the research guiding the pharmacologic treatment of symptoms associated with autism and related PDDs. Areas of focus for future research are also discussed. The need for large-scale investigation of some commonly used pharmacologic agents, in addition to the development of drugs with improved efficacy and safety profiles, is made evident. Take home message: Despite progress in the development of pharmacologic treatments for a number of interfering symptom domains associated with autism and other PDDs, a great deal of work remains.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Substance Abuse

Alcohol affects the P3 component of an adaptive stop signal task ERP

Martin H. Plawecki, Kyle A. Windisch, Leah Wetherill, Ann E. K. Kosobud, Mario Dzemidzic, David A. Kareken, Sean J. O'Connor

ALCOHOL (2018)

Article Substance Abuse

Comparison of Subjective Responses to Oral and Intravenous Alcohol Administration Under Similar Systemic Exposures

Martin Henry Plawecki, Adnan Mahmood Durrani, Julian Boes, Leah Wetherill, Ann Kosobud, Sean O'Connor, Vijay A. Ramchandani

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2019)

Review Substance Abuse

To Infuse or Ingest in Human Laboratory Alcohol Research

Melissa A. Cyders, Martin H. Plawecki, William Corbin, Andrea King, Denis M. McCarthy, Vijay A. Ramchandani, Jessica Weafer, Sean J. O'Connor

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Substance Abuse

Intoxication Effects on Impulsive Alcohol Choice in Heavy Drinkers: Correlation With Sensation Seeking and Differential Effects by Commodity

Brandon G. Oberlin, Claire R. Carron, Nolan E. Ramer, Martin H. Plawecki, Sean J. O'Connor, David A. Kareken

Summary: The study found that heavy drinkers who are high sensation seekers are more likely to make impulsive alcohol choices when intoxicated, indicating a potential interaction that may contribute to impaired control over drinking. In general, the tendency towards immediate rewards and sensation seeking can affect alcohol consumption behavior.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Binge and high-intensity drinking-Associations with intravenous alcohol self-administration and underlying risk factors

Martin H. Plawecki, Julian Boes, Leah Wetherill, Ann E. K. Kosobud, Bethany L. Stangl, Vijay A. Ramchandani, Ulrich S. Zimmermann, John I. Nurnberger, Marc Schuckit, Howard J. Edenberg, Gayathri Pandey, Chella Kamarajan, Bernice Porjesz, Tatiana Foroud, Sean O'Connor

Summary: This study investigates the relationship between alcohol consumption patterns and the risk of alcohol use disorder. The researchers propose that the brain is sensitive to the rate of change in alcohol concentration, and individuals at higher risk are more likely to self-administer alcohol at a faster rate. They develop a unique intravenous alcohol self-administration paradigm that allows participants to control the speed at which their breath alcohol concentration changes. The study finds that shorter time to reach a certain alcohol concentration is associated with higher binge drinking intensity and family history of alcoholism. Subjective responses to alcohol, such as intoxication and stimulation, also show a rate-dependent association with family history of alcoholism. The researchers suggest that their rate control paradigm can be used to examine the pharmacokinetics and pharmacodynamics of alcohol and potentially predict the risk for alcohol use disorders.

ADDICTION BIOLOGY (2022)

Article Substance Abuse

Fat-free mass accounts for most of the variance in alcohol elimination rate in women

Neda Seyedsadjadi, Vijay A. Ramchandani, Martin H. Plawecki, Ann E. K. Kosobud, Sean O'Connor, Blair Rowitz, Marta Yanina Pepino

Summary: In this study, data from 143 women were analyzed, and it was found that obesity and older age were associated with faster alcohol elimination rates. However, the impact of obesity on alcohol elimination rates was mediated by an increase in fat-free mass. Additionally, bariatric surgery did not have a significant effect on alcohol elimination rates.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Substance Abuse

Free-access intravenous alcohol self-administration in social drinkers and individuals with alcohol use disorder: Evaluation of relationships with phosphatidylethanol and self-reported alcohol consumption

Yasmin Olsson, Kenan Hodzic, Caroline Wass, Helga Lido, Bethany L. Stangl, Sean O'Connor, Martin H. Plawecki, Vijay A. Ramchandani, Bo Soderpalm, Elisabet Jerlhag

Summary: The free-access intravenous alcohol self-administration (FA-IV-ASA) paradigm can reflect drinking in social drinkers (SD) but not in individuals with mild alcohol use disorder (AUD). Further studies with a larger AUD sample are needed to better evaluate the FA-IV-ASA method.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Neurosciences

High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study

Jonathan Alessi, Mario Dzemidzic, Katherine Benson, George Chittum, Ann Kosobud, Jaroslaw Harezlak, Martin H. Plawecki, Sean J. O'Connor, David A. Kareken

Summary: This study investigated the neural basis of the association between high-intensity sweet-liking and alcohol use disorder (AUD) risk. Using functional magnetic resonance imaging (fMRI), the researchers found that the liking of high-concentration sucrose taste was positively correlated with brain responses in the supplementary motor area and right dorsal anterior insula, which are known to be involved in the salience network.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Education & Educational Research

Evaluation of US Medical Student Bias Toward Mental Health Before and After First-Year Pre-clinical Psychiatry Education

Alyssa C. Smith, Michael J. Opperman, Joseph P. McCann, Morgan P. Jivens, Julianne Giust, Leah Wetherill, Martin H. Plawecki

Summary: The study found that psychiatric education for medical students can reduce bias towards patients with mental health conditions, leading to improved outcomes. However, there is still significant bias against mental illness and psychiatry among US medical students. Healthcare educators should be aware of these biases and their potential impact on patient outcomes.

ACADEMIC PSYCHIATRY (2023)

Article Substance Abuse

Brain response in heavy drinkers during cross-commodity alcohol and money discounting with potentially real rewards: A preliminary study

Elizabeth A. Lungwitz, Mario Dzemidzic, Yitong I. Shen, Martin H. Plawecki, Brandon G. Oberlin

Summary: This study measured brain activation in heavy drinkers during a cross-commodity delay discounting task and found that alcohol decision-making elicited activation in regions governing reward, introspection, and executive decision-making. There were no differences between immediate and delayed choices, suggesting that the brain processes underlying these choices are mostly overlapping.

DRUG AND ALCOHOL DEPENDENCE REPORTS (2023)

Article Education, Scientific Disciplines

Medical Student Engagement in a Virtual Learning Environment Positively Correlates with Course Performance and Satisfaction in Psychiatry

Larrilyn L. Grant, Michael J. Opperman, Brennan Schiller, Jonathan Chastain, Jennelle Durnett Richardson, Christine Eckel, Martin H. Plawecki

Summary: This study evaluated the flipped classroom approach in medical education, specifically focusing on student engagement and performance. The results showed a positive relationship between student engagement and academic performance, with students and facilitators both perceiving the approach positively. Future research should focus on overall performance in standardized tests and other aspects of medical education.

MEDICAL SCIENCE EDUCATOR (2021)

Meeting Abstract Substance Abuse

THE RELATIONSHIP BETWEEN INTRAVENOUS ALCOHOL SELF-ADMINISTRATION AND BRAIN-REWARD SYSTEM RESPONSES TOMONETARY REWARD ANTICIPATION IN YOUNG ADULT DRINKERS

S. S. Janetsian-Fritz, A. E. K. Kosobud, W. J. A. Eiler, C. M. Soeurt, B. G. Oberlin, S. J. O'Connor, M. H. Plawecki, J. Harezlak, M. Dzemidzic, D. A. Kareken

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

Meeting Abstract Substance Abuse

CLUSTERING OF INTRAVENOUS SELF-ADMINISTRATION OF ALCOHOL IN A LABORATORY SETTING REFLECTS REAL LIFE DRINKING AND ALCOHOL USE DISORDER RISK

A. E. K. Kosobud, C. R. Carron, M. H. Plawecki, C. M. Soeurt, S. J. O'Connor, J. Harezlak, D. A. Kareken

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

Meeting Abstract Substance Abuse

INTRAVENOUS ALCOHOL SELF-ADMINISTRATION IN PARTICIPANTS WITH ALCOHOL USE DISORDER: COMPARING EFFECT SIZES BETWEEN FREE-ACCESS AND PROGRESSIVE RATIO PARADIGMS

C. N. Nona, C. Chukwueke, M. D. McPhee, L. M. Heath, J. D. Wardell, S. Malik, M. H. Plawecki, S. O'Connor, V. A. Ramchandani, B. Le Foil, C. S. Hendershot

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

Meeting Abstract Substance Abuse

HUMAN ALCOHOL SEEKING DESPITE AVERSION - PRELIMINARY DATA WITH INTRAVENOUS ALCOHOL SELF-ADMINISTRATION

M. H. Plawecki, M. Cyders, V. Vitvitskiy, J. D. Haines, J. Hays, S. Velamakanni, A. Kosobud, L. Wetherill, D. Kareken, S. J. O'Connor

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

暂无数据